Latest News Releases From The Newsroom
Canaccord Bullish on Joby Aviation, Lilium, Vertical Aerospace, Eve, Archer Aviation: eVTOL Stocks
June 09th, 2023
Joby Aviation, Inc. (NYSE: JOBY), a leading electric aviation company focused on the development of vertical takeoff and landing (VTOL) aircraft, has been initiated with a Buy rating and Price Target of $8 by Canaccord Genuity. With $JOBY cl. Read more
Braze, Duckhorn, General Motors, and Tesla: Earnings, Guidance, and Collaboration Updates
June 09th, 2023
Braze, Inc. (Nasdaq: BRZE) reported a first-quarter fiscal 2024 loss of $0.13 per share, better than the consensus estimate of a loss of $0.18 per share. The company has also provided guidance for the second quarter, expecting an adjusted lo. Read more
A Snapshot of Potential Upsides: Oculis, Zscaler, MercadoLibre, FIGS, Home Depot, AMETEK
June 09th, 2023
Oculis Holding AG (Nasdaq: OCS), a leading pharmaceutical company specializing in developing innovative therapies for ocular diseases, has been initiated with an Outperform rating and a price target of $58 by Robert W. Baird. With $OCS closing at . Read more
Raytheon Secures $372.14M Contract; FDA OKs Sientra's MRI-Compatible Tissue Expander AlloX2 Pro
June 08th, 2023
Raytheon Intelligence & Space, a key business segment of Raytheon Technologies Corp. (NYSE: RTX), has been awarded a significant contract worth $372,137,000 by the Naval Air Warfare Center Weapons Division. The contract entails updates, impr. Read more
DocuSign Q1 Beats, ContraFect Conference Buzz, Bullish Sentiment Towards Uber and Lufax
June 08th, 2023
DocuSign, Inc. (Nasdaq: DOCU), a renowned provider of electronic signature technology and digital transaction management services, reported its first-quarter fiscal 2024 financial results. The company exceeded expectations with adjusted earnings per . Read more
FTC Further Expands Inquiry Into Prescription Drug Middlemen Industry Practices
June 08th, 2023
Agency issues order to additional GPO as it examines the impact of vertically integrated PBMs on prescription drug prices and access Washington D.C. / CRWE PRESS RELEASE / June 8, 2023 - As part of its ongoing study on pharmacy be. Read more
President Joe Biden Responds to Wildfires in Canada: A Call for Action on Climate Change
June 08th, 2023
The devastating wildfires in Canada have once again brought attention to the urgent issue of climate change, with millions of Americans experiencing the effects of the resulting smoke. President Joe Biden has issued a statement emphasizing the need f. Read more
Early Movers, Market Snapshot: Alithya Group, Carvana and Lakeland Industries
June 08th, 2023
Alithya Group Inc. (Nasdaq: ALYA) has released its fourth-quarter fiscal 2023 results, reporting adjusted earnings per share (EPS) of $0.04, a notable increase from $0.02 in the same quarter last year. The company also achieved a 13.5% growth in reve. Read more
REV Group, Signet Jewelers, and The Toro Company: Quarterly Numbers and Market Reactions
June 08th, 2023
REV Group, Inc. (NYSE: REVG) has announced its second-quarter fiscal 2023 results, with adjusted earnings per share (EPS) of $0.35, surpassing the consensus estimate of $0.18. Additionally, the company has raised its full-year fiscal 2023 ne. Read more
Chindata & SciPlay: Special Committees Review Proposals; FuelCell Energy Miss Forecasts
June 08th, 2023
Chindata Group Holdings Limited (Nasdaq: CD) has announced the formation of a special committee to review a non-binding proposal from BCPE Bridge Cayman, L.P. and BCPE Stack Holdings, L.P. The proposal suggests acquiring all outstanding ordi. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025




Member Login